These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 12728786

  • 1. [Role of the renin-angiotensin system in the pathogenesis, clinical picture and treatment of diabetic nephropathy].
    Wittmann I, Degrell P, Komáromy A, Molnár GA, Wagner Z, Wagner L, Mazák I, Nagy J.
    Orv Hetil; 2003 Mar 30; 144(13):613-9. PubMed ID: 12728786
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus.
    Hughes DB, Britton ML.
    Pharmacotherapy; 2005 Nov 30; 25(11):1602-20. PubMed ID: 16232022
    [Abstract] [Full Text] [Related]

  • 3. [Clinical studies on chronic diabetic nephropathy and recent data concerning prevention of risks of nephropathy and cardiovascular diseases].
    Esnault V.
    Nephrol Ther; 2006 May 30; 2 Suppl 3():S193-6. PubMed ID: 17370850
    [Abstract] [Full Text] [Related]

  • 4. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
    Wade VL, Gleason BL.
    Ann Pharmacother; 2004 May 30; 38(7-8):1278-82. PubMed ID: 15187210
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The renin-angiotensin system and diabetic nephropathy.
    Gurley SB, Coffman TM.
    Semin Nephrol; 2007 Mar 30; 27(2):144-52. PubMed ID: 17418683
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The role of angiotensin II AT1-receptor antagonists in renal and cardiac protection in type-2 diabetes mellitus].
    Ravera M, Deferrari L, Ratto E, Vettoretti S, Parodi D, Deferrari G.
    Ital Heart J Suppl; 2003 Mar 30; 4(3):210-6. PubMed ID: 12784755
    [Abstract] [Full Text] [Related]

  • 9. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct 30; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 10. Optimizing antihypertensive therapy in patients with diabetic nephropathy.
    Ritz E, Rychlík I, Miltenberger-Miltenyi G.
    J Hypertens Suppl; 1998 Sep 30; 16(7):S17-22. PubMed ID: 9855027
    [Abstract] [Full Text] [Related]

  • 11. Dual blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy: the role of aldosterone.
    Schjoedt KJ, Jacobsen P, Rossing K, Boomsma F, Parving HH.
    Horm Metab Res; 2005 Apr 30; 37 Suppl 1():4-8. PubMed ID: 15918104
    [Abstract] [Full Text] [Related]

  • 12. Effect of genetic variation on therapy with angiotensin converting enzyme inhibitors or angiotensin receptor blockers in dialysis patients.
    Böger CA, Götz AK, Krüger B, Hösl M, Schmitz G, Riegger GA, Krämer BK.
    Eur J Med Res; 2005 Apr 20; 10(4):161-8. PubMed ID: 15946912
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.
    Seki N, Hashimoto N, Suzuki Y, Yagui K, Saito Y.
    Diabetes Res Clin Pract; 2006 May 20; 72(2):135-41. PubMed ID: 16290123
    [Abstract] [Full Text] [Related]

  • 14. Diabetes, nephropathy, and the renin system.
    Hollenberg NK.
    J Hypertens Suppl; 2006 Mar 20; 24(1):S81-7. PubMed ID: 16601578
    [Abstract] [Full Text] [Related]

  • 15. Losartan in diabetic nephropathy.
    Perico N, Ruggenenti P, Remuzzi G.
    Expert Rev Cardiovasc Ther; 2004 Jul 20; 2(4):473-83. PubMed ID: 15225108
    [Abstract] [Full Text] [Related]

  • 16. [Multilevel blockade of the renin-angiotensin-aldosterone system in the treatment of diabetic nephropathy].
    Fronczyk A, Majkowska L.
    Przegl Lek; 2007 Jul 20; 64(2):81-5. PubMed ID: 17892038
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effects of angiotensin II inhibition or blockade on the progression of chronic renal disease.
    Cantarovich F, Rangoonwala B.
    Int J Clin Pract; 2003 Nov 20; 57(9):801-22. PubMed ID: 14686572
    [Abstract] [Full Text] [Related]

  • 18. Combination therapy with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in the treatment of patients with type 2 diabetes mellitus.
    Rosner MH, Okusa MD.
    Arch Intern Med; 2003 May 12; 163(9):1025-9. PubMed ID: 12742799
    [Abstract] [Full Text] [Related]

  • 19. Advances in the treatment of diabetic renal disease: focus on losartan.
    Rayner B.
    Curr Med Res Opin; 2004 Mar 12; 20(3):333-40. PubMed ID: 15025842
    [Abstract] [Full Text] [Related]

  • 20. The renin-angiotensin-aldosterone system and its blockade in diabetic nephropathy: main focus on the role of aldosterone.
    Schjoedt KJ.
    Dan Med Bull; 2011 Apr 12; 58(4):B4265. PubMed ID: 21466768
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.